NOVEL CAR T THAT TARGETS MUC1*NOT FULL-LENGTH MUC1 FOR TREATMENT OF SOLID TUMOR CANCERS

被引：2
|
作者：
Bamdad, C. [1 ]
Stewart, A. K. [1 ]
Smagghe, B. J. [1 ]
Huang, P. [1 ]
Glennie, N. D. [1 ]
Deary, L. T. [1 ]
机构：
[1] Minerva Biotechnol, Waltham, MA USA
来源：
CYTOTHERAPY | 2018年 / 20卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2018.02.007
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] MUC1 immunotherapy
    Beatson, Richard E.
    Taylor-Papadimitriou, Joyce
    Burchell, Joy M.
    IMMUNOTHERAPY, 2010, 2 (03) : 305 - 327
  • [22] RUNNING A MUC1
    McCarthy, Nicola
    NATURE REVIEWS CANCER, 2012, 12 (05) : 317 - 317
  • [23] Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model
    Rowse, GJ
    Tempero, RM
    VanLith, ML
    Hollingsworth, MA
    Gendler, SJ
    CANCER RESEARCH, 1998, 58 (02) : 315 - 321
  • [24] Mimic 1 of MUC1
    Finn, OJ
    Gendler, SJ
    NATURE BIOTECHNOLOGY, 1998, 16 (03) : 236 - 237
  • [25] Mimic 1 of MUC1
    Olivera J. Finn
    Sandra J. Gendler
    Nature Biotechnology, 1998, 16 : 236 - 237
  • [26] Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model
    Tempero, RM
    Morikane, K
    Vanlith, ML
    Gendler, SJ
    Hollingsworth, MA
    FASEB JOURNAL, 1998, 12 (05): : A891 - A891
  • [27] 1ST-IN-HUMAN CAR T TARGETS THE GROWTH FACTOR RECEPTOR FORM OF MUC1
    Bamdad, C.
    Smagghe, B. J.
    Carter, M. G.
    Grant, T.
    Page, D.
    Yi, K. Y.
    Nash, J.
    Reale, L. M.
    Nash, M. J.
    Stewart, A. K.
    CYTOTHERAPY, 2022, 24 (05) : S108 - S108
  • [28] Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice
    Ryan, Sean O.
    Vlad, Anda M.
    Islam, Kazi
    Gariepy, Jean
    Finn, Olivera J.
    BIOLOGICAL CHEMISTRY, 2009, 390 (07) : 611 - 618
  • [29] Immunogenic MUC1 glycopeptides can be generated when dendritic cells (DCs) are primed with microvescicle bound MUC1 tumor associated glycoprotein, but not with soluble MUC1
    Zizzari, I. G.
    Rahimi, H.
    Battisti, F.
    Napoletano, C.
    Belleudi, F.
    Visconti, V.
    Wandall, H.
    Burchell, J.
    Torrisi, M. R.
    Nuti, M.
    Rughetti, A.
    IMMUNOLOGY, 2012, 137 : 714 - 714
  • [30] First-in-human CAR T targets MUC1 transmembrane cleavage product.
    Bamdad, Cynthia
    Stewart, Andrew K.
    Huang, Pengyu
    Smagghe, Benoit J.
    Moe, Scott T.
    Swanson, Tyler E.
    Jeon, Thomas G.
    Page, Danica M.
    Grant, Trevor J.
    Specht, Jennifer M.
    CANCER RESEARCH, 2021, 81 (13)
12345